OBJECTIVE: To establish a HPLC method for the determination of celiprolol in human plasma and investigate the pharmacokinetic characteristics of celiprolol in normal subjects after a single oral dose. METHODS: The plasma was extracted with ethyl acetate, sulfuric acid after base purification. The mobile phase was an aqueous solution containing acetonitrile and phosphate buffer. Absorbance of the effluent was monitored at 237 nm. RESULTS: The method was linear within the range of 10 to 5 000 μg·L-1 and the limit of detection was 2 ng·ml-1. The average relative diviation (RSD) of within day ranged from 1.70% to 4.06%, and day to day from 1.86% to 4.03%. The recoveries of celiprolol were (97.78±2.90)% to (102.00±3.10)%. CONCLUSION: The method permits characterization of the pharmacokinetics and pharmacodynamics of celiprolol in clinical setting.
Dun Jingli .
Determination of celiprolol in plasma by HPLC and application study of pharmacokinetics [J]. Chinese Pharmaceutical Journal, 1998, 33(02): 98-100
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
1 Milne RJ,Buckly MT.Celiprolol.Drugs,1991,41:941.
2 Buskin JN,Upton RA,Sorgel F,et al.Specific and sensitive assay of celiprolol in b1ood,plasma and urine using highperformance liquide chromatography,J Chromatogr,1982,230:454.
3 Hartmann C,Krauss D,Spahn H.Et al.Simultaneous determination of ?-and(s)-celiprolol in human plasma and urine:high-performance luquide chromatographic essay on a chiral stationary phase with fluorimetric detection.J Chromatogr,1989,496:387.